E-resources
-
Chaplin, Steve
Prescriber (London, England), February 2022, 2022-02-00, 20220201, Volume: 33, Issue: 2Journal Article
There are numerous biological and small‐molecule therapies currently under investigation for the prevention and treatment of COVID‐19. This article focuses on antibody therapies that target the virus itself, including convalescent plasma and monoclonal antibodies against SARS‐CoV‐2, and discusses their efficacy in clinical trials and likely future role.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.